J-GLOBAL ID:201901017247929504   Update date: Jun. 15, 2023

Satoh Masahiro

サトウ マサヒロ | Satoh Masahiro
Affiliation and department:
Job title: Researh Fellow
Research field  (1): Cardiology
Research theme for competitive and other funds  (1):
  • 2017 - 2019 Establishment of precision medicine for cardiomyopathy using genome analysis and single cell analysis
Papers (11):
  • TAKANOBU YAMADA, SEITARO NOMURA, EISUKE AMIYA, MANAMI KATOH, SHUNSUKE INOUE, SATOSHI HATSUSE, KANNA FUJITA, MASAMICHI ITO, TAKANORI FUJITA, CHIE BUJO, et al. LMNA Mutations and Right Heart Failure in Patients With Cardiomyopathy and With Left Ventricular Assist Devices. Journal of Cardiac Failure. 2023. 29. 5. 855-857
  • Toshiyuki Ko, Seitaro Nomura, Shintaro Yamada, Kanna Fujita, Takanori Fujita, Masahiro Satoh, Chio Oka, Manami Katoh, Masamichi Ito, Mikako Katagiri, et al. Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-β-IGFBP7 axis. Nature Communications. 2022. 13. 1
  • Masato Ishizuka, Mutsuo Harada, Seitaro Nomura, Toshiyuki Ko, Yuichi Ikeda, Jiaxi Guo, Satoshi Bujo, Haruka Yanagisawa-Murakami, Masahiro Satoh, Shintaro Yamada, et al. CXCR7 ameliorates myocardial infarction as a β-arrestin-biased receptor. Scientific reports. 2021. 11. 1. 3426-3426
  • Toshihiro Yamaguchi, Tomokazu S Sumida, Seitaro Nomura, Masahiro Satoh, Tomoaki Higo, Masamichi Ito, Toshiyuki Ko, Kanna Fujita, Mary E Sweet, Atsushi Sanbe, et al. Cardiac dopamine D1 receptor triggers ventricular arrhythmia in chronic heart failure. Nature communications. 2020. 11. 1. 4364-4364
  • Toshiyuki Ko, Kanna Fujita, Seitaro Nomura, Yukari Uemura, Shintaro Yamada, Takashige Tobita, Manami Katoh, Masahiro Satoh, Masamichi Ito, Yukako Domoto, et al. Quantification of DNA Damage in Heart Tissue as a Novel Prediction Tool for Therapeutic Prognosis of Patients With Dilated Cardiomyopathy. JACC. Basic to translational science. 2019. 4. 6. 670-680
MISC (2):
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page